These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 29943445)

  • 1. Ratings surveillance and reliability in a study of major depressive disorder with subthreshold hypomania (mixed features).
    Targum SD; Pendergrass JC; Lee S; Loebel A
    Int J Methods Psychiatr Res; 2018 Dec; 27(4):e1729. PubMed ID: 29943445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Double-blind, placebo-controlled study of lurasidone monotherapy for the treatment of bipolar I depression.
    Kato T; Ishigooka J; Miyajima M; Watabe K; Fujimori T; Masuda T; Higuchi T; Vieta E
    Psychiatry Clin Neurosci; 2020 Dec; 74(12):635-644. PubMed ID: 32827348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lurasidone in the treatment of bipolar depression with mixed (subsyndromal hypomanic) features: post hoc analysis of a randomized placebo-controlled trial.
    McIntyre RS; Cucchiaro J; Pikalov A; Kroger H; Loebel A
    J Clin Psychiatry; 2015 Apr; 76(4):398-405. PubMed ID: 25844756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Lurasidone on Sexual Function in Major Depressive Disorder Patients With Subthreshold Hypomanic Symptoms (Mixed Features): Results From a Placebo-Controlled Trial.
    Clayton AH; Tsai J; Mao Y; Pikalov A; Loebel A
    J Clin Psychiatry; 2018 Aug; 79(5):. PubMed ID: 30086213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features: A Randomized, Double-Blind, Placebo-Controlled Study.
    Suppes T; Silva R; Cucchiaro J; Mao Y; Targum S; Streicher C; Pikalov A; Loebel A
    Am J Psychiatry; 2016 Apr; 173(4):400-7. PubMed ID: 26552942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Audio-digital recordings for surveillance in clinical trials of major depressive disorder.
    Targum SD; Catania CJ
    Contemp Clin Trials Commun; 2019 Jun; 14():100317. PubMed ID: 30705991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Audio-digital recordings used for independent confirmation of site-based MADRS interview scores.
    Targum SD; Pendergrass JC; Toner C; Asgharnejad M; Burch DJ
    Eur Neuropsychopharmacol; 2014 Nov; 24(11):1760-6. PubMed ID: 25239474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lurasidone for major depressive disorder with mixed features and irritability: a post-hoc analysis.
    Swann AC; Fava M; Tsai J; Mao Y; Pikalov A; Loebel A
    CNS Spectr; 2017 Apr; 22(2):228-235. PubMed ID: 28300012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lurasidone Efficacy in Mixed Depressive States: A Comparison of Standard Rating Scales to the Koukopoulos Mixed Depression Rating Scale.
    Vöhringer PA; Sani G; Barroilhet SA; Mao Y; Ghaemi SN
    J Clin Psychopharmacol; 2020; 40(5):491-494. PubMed ID: 32701901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of asenapine on manic and depressive symptoms in bipolar I patients with mixed episodes: results from post hoc analyses.
    Azorin JM; Sapin C; Weiller E
    J Affect Disord; 2013 Feb; 145(1):62-9. PubMed ID: 22868059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lurasidone in Children and Adolescents with Bipolar Depression Presenting with Mixed (Subsyndromal Hypomanic) Features:
    Singh MK; Pikalov A; Siu C; Tocco M; Loebel A
    J Child Adolesc Psychopharmacol; 2020 Dec; 30(10):590-598. PubMed ID: 32392455
    [No Abstract]   [Full Text] [Related]  

  • 12. Major depressive disorder with mixed features and treatment response to lurasidone: A symptom network model.
    Goldberg JF; Siu C; Mao Y; Tsai J; Pikalov A; Calabrese JR; Loebel A
    J Affect Disord; 2020 Dec; 277():1045-1054. PubMed ID: 33065813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lurasidone in post-menopausal females with major depressive disorder with mixed features: Post-hoc analysis of a placebo-controlled trial.
    Sramek J; Loebel A; Murphy M; Mao Y; Pikalov A; Cutler NR
    Prog Neuropsychopharmacol Biol Psychiatry; 2017 Aug; 78():12-17. PubMed ID: 28499900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cariprazine for the treatment of bipolar mania with mixed features: A post hoc pooled analysis of 3 trials.
    McIntyre RS; Masand PS; Earley W; Patel M
    J Affect Disord; 2019 Oct; 257():600-606. PubMed ID: 31344528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lurasidone Dose Response in Bipolar Depression: A Population Dose-response Analysis.
    Chapel S; Chiu YY; Hsu J; Cucchiaro J; Loebel A
    Clin Ther; 2016 Jan; 38(1):4-15. PubMed ID: 26730454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of BPRS interview length on ratings reliability in a schizophrenia trial.
    Targum SD; Cara Pendergrass J; Toner C; Zumpano L; Rauh P; DeMartinis N
    Eur Neuropsychopharmacol; 2015 Mar; 25(3):312-8. PubMed ID: 25554563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First controlled treatment trial of bipolar II hypomania with mixed symptoms: quetiapine versus placebo.
    Suppes T; Ketter TA; Gwizdowski IS; Dennehy EB; Hill SJ; Fischer EG; Snow DE; Gonzalez R; Sureddi S; Shivakumar G; Cosgrove VE
    J Affect Disord; 2013 Aug; 150(1):37-43. PubMed ID: 23521871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lurasidone adjunctive with lithium or valproate for bipolar depression: A placebo-controlled trial utilizing prospective and retrospective enrolment cohorts.
    Suppes T; Kroger H; Pikalov A; Loebel A
    J Psychiatr Res; 2016 Jul; 78():86-93. PubMed ID: 27089521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Remission and recovery associated with lurasidone in the treatment of major depressive disorder with subthreshold hypomanic symptoms (mixed features): post-hoc analysis of a randomized, placebo-controlled study with longer-term extension.
    Goldberg JF; Ng-Mak D; Siu C; Chuang CC; Rajagopalan K; Loebel A
    CNS Spectr; 2017 Apr; 22(2):220-227. PubMed ID: 28264739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and Effectiveness of Long-Term Treatment with Lurasidone in Older Adults with Bipolar Depression: Post-Hoc Analysis of a 6-Month, Open-Label Study.
    Forester BP; Sajatovic M; Tsai J; Pikalov A; Cucchiaro J; Loebel A
    Am J Geriatr Psychiatry; 2018 Feb; 26(2):150-159. PubMed ID: 29146409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.